0001140361-24-030210.txt : 20240614
0001140361-24-030210.hdr.sgml : 20240614
20240614170046
ACCESSION NUMBER: 0001140361-24-030210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Auerbach Michael
CENTRAL INDEX KEY: 0001746080
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 241045764
MAIL ADDRESS:
STREET 1: 158 HESTER STREET
STREET 2: APT 7F
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
form4.xml
FORM 4
X0508
4
2024-06-13
0001840904
ATAI Life Sciences N.V.
ATAI
0001746080
Auerbach Michael
C/O SUBVERSIVE ATAI, LLC
217 CENTRE STREET, SUITE 122
NEW YORK
NY
10013
true
false
Stock Option
1.34
2024-06-13
4
A
0
103000
0
A
2034-06-13
Common Shares
103000
103000
D
The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 13, 2025.
/s/ Ryan Barrett, Attorney-in-fact
2024-06-14